Analysis of global, regional, and national burdens of neonatal encephalopathy from 1990 to 2021: insights from the Global Burden of Disease Study 2021.

ABSTRACT:

Background

The Sustainable Development Goal 3.2 urges nations to reduce neonatal mortality rates to no more than 12 deaths per 1,000 live births by 2030. Neonatal encephalopathy (NE), the third leading cause of under-five mortality, significantly impacts global neonatal death rates and long-term health. A comprehensive assessment is essential to inform public health strategies. This study aims to analyze the burden of Neonatal Encephalopathy on global, regional, and national levels.

Methods

Data on the age-standardized mortality rate (ASMR) and age-standardized incidence rates (ASIR) for NE from 1990 to 2021 were obtained from the Global Burden of Disease Study (GBD) 2021. To evaluate the changes in ASIR and ASMR associated with the burden of NE, estimated annual percentage

SUBMITTER: Tan S 

PROVIDER: S-EPMC12540312 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature